...
首页> 外文期刊>Immunopharmacology >The restoration of the antitumor T cell response from stress-induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41:Bu-Zhong-Yi-Qi-Tang).
【24h】

The restoration of the antitumor T cell response from stress-induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41:Bu-Zhong-Yi-Qi-Tang).

机译:使用中草药Hochu-ekki-to(TJ-41:Bu-Zhong-Yi-Qi-Tang-Tang)从压力诱导的抑制中恢复抗肿瘤T细胞反应。

获取原文
获取原文并翻译 | 示例
           

摘要

We previously reported that restraint stress impairs the antitumor immune responses through its suppressive effect on the Th1-type cytokine production from CD4+ T cells. In this study, we investigated a potential of Hochu-ekki-to (TJ-41:Bu-Zhong-Yi-Qi-Tang) to restore stress-induced immunosuppression. The oral administration of TJ-41 was able to improve a decreased cellularity in the lymph node and spleen and to improve an inhibition of tumor-specific Th1-type cytokine production, both of which were induced by repeated restraint stress in tumor-bearing mice. The oral administration of TJ-41 also induced a partial recovery of the antitumor cytolytic activity in the stress-burdened tumor-bearing mice. More importantly, the growth of tumors in stress-burdened preimmunized mice was obviously inhibited by TJ-41, and resulted in tumor-free state in 75% of the mice. Regarding the mechanisms by which TJ-41 restored the antitumor responses in stress-burdened mice, we found that the serum levels of corticosterone and interleukin-12 were normalized by TJ-41. In addition, the expression of CD80 and CD86, which both decreased in the stress-burdened mice, was restored to the normal level by TJ-41. Taken together, our results indicate that the oral administration of TJ-41 is able to restore the antitumor T cell responses in stress-burdened tumor-bearing mice by normalizing the serum corticosterone, interleukin-12 and the expression of costimulatory molecules.
机译:我们以前曾报道过,抑制性应激通过抑制CD4 + T细胞Th1型细胞因子的产生而削弱了抗肿瘤免疫反应。在这项研究中,我们研究了Hochu-ekki-to(TJ-41:Bu-Zhong-Yi-Qi-Tang)恢复应激诱导的免疫抑制的潜力。口服TJ-41能够改善淋巴结和脾脏细胞密度的降低,并改善对肿瘤特异性Th1型细胞因子产生的抑制作用,这两者都是由荷瘤小鼠反复受到束缚应激诱导的。口服施用TJ-41还可以在荷重肿瘤的荷瘤小鼠中部分恢复抗肿瘤细胞溶解活性。更重要的是,TJ-41明显抑制了应激负担的预免疫小鼠的肿瘤生长,并导致75%的小鼠处于无肿瘤状态。关于TJ-41恢复应激小鼠的抗肿瘤反应的机制,我们发现TJ-41使血清皮质酮和白介素12水平正常化。另外,在应激负荷小鼠中都降低的CD80和CD86的表达通过TJ-41恢复到正常水平。两者合计,我们的结果表明口服TJ-41能够通过使血清皮质酮,白介素12和共刺激分子的表达正常化,从而在荷重的荷瘤小鼠中恢复抗肿瘤T细胞反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号